1 Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients.

2 [Acute myeloid leukemia with sudden onset bilateral lower extremity paralysis caused by disseminated mucormycosis following unrelated bone marrow transplantation].

3 Antiviral activity of itraconazole against type I feline coronavirus infection.

4 Overall survival of glasdegib in combination with low-dose cytarabine, azacitidine, and decitabine among adult patients with previously untreated AML: comparative effectiveness using simulated treatment comparisons.

5 Antiproliferative and Immunoregulatory Effects of Azelaic Acid Against Acute Myeloid Leukemia the Activation of Notch Signaling Pathway.

6 Two Receptors, Two Isoforms, Two Cancers: Comprehensive Analysis of KIT and TrkA Expression in Neuroblastoma and Acute Myeloid Leukemia.

7 Distinct downstream signaling and the roles of VEGF and PlGF in high glucose-mediated injuries of human retinal endothelial cells in culture.

8 Vitamin B6 Addiction in Acute Myeloid Leukemia.

9 the intriguing occurrence of acute myeloid leukemia in a case of acute lymphoblastic leukemia:report of two cases

10 a case of acute myeloid leukemia presenting with deep venous thrombosis

11 selection of tumor-specific cytotoxic t lymphocytes in acute myeloid leukemia patients through the identification of t-cells capable to establish stable interactions with the leukemic cells: “doublet technology”

12 cyanobacteria from terrestrial and marine sources contain apoptogens able to overcome chemoresistance in acute myeloid leukemia cells

13 azelaic acid exerts antileukemic activity in acute myeloid leukemia

14 modeling myeloid malignancies using zebrafish

15 an unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and runx1–mecom fusion transcripts

16 acute myeloid leukemia in turkish children with fanconi anemia. one center experience in the period between 1964-1995

17 successful treatment of intracranial hemorrhage with recombinant activated factor vii in a patient with newly diagnosed acute myeloid leukemia: a case report and review of the literature

18 acute monoblastic leukemia with abnormal eosinophils and inversion (16): a rare entity

19 tacrolimus associated posterior reversible encephalopathy syndrome – a case series and review

20 family platelet disorder with propensity to acute myeloid leukemia: new family with runx1 mutation

21 o transplante de medula óssea na leucemia mielóide aguda: análise de 80 pacientes transplantados no complexo do hospital das clínicas da faculdade de medicina da universidade de são paulo the allogeneic and autologous bone marrow transplantation in acute myeloid leukemia: analysis of 80 patients - bone marrow transplantation service - hospital das clínicas of the medical school, university of são paulo

22 Acute Myeloid Leukemia with Concomitant BCR-ABL and NPM1 Mutations

23 [Precision medicine for acute myeloid leukemia based on genomic profiling].

24 New drugs approved for acute myeloid leukemia (AML) in 2018.

25 Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells

26 Patient-Centered Insights on Treatment Decision Making and Living with Acute Myeloid Leukemia and Other Hematologic Cancers.

27 Prophylactic Measures During Induction for Acute Myeloid Leukemia.

28 In vitro activity of a G-quadruplex-stabilizing small molecule that synergizes with Navitoclax to induce cytotoxicity in acute myeloid leukemia cells.

29 The impact of concomitant cytogenetic abnormalities on acute myeloid leukemia with monosomy 7 or deletion 7q after HLA-matched allogeneic stem cell transplantation.

30 The prevalence, risk factors, and prognostic value of anxiety and depression in refractory or relapsed acute myeloid leukemia patients of North China.

31 Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.

32 Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.

33 Publisher Correction: The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia (Nature Communications, (2019), 10, 1, (5351), 10.1038/s41467-019-13259-2)

34 [The impact of KIT and other concomitant gene mutations on the prognoses of patients with core-binding factor acute myeloid leukemia].

35 Molecularly targeted therapies in myelodysplastic syndromes and acute myeloid leukemias

36 Prognostic impact of low allelic ratio FLT3- ITD and NPM1 mutation in acute myeloid leukemia

37 Significance of FLT3-tyrosine kinase domain mutation as a prognostic factor for acute myeloid leukemia

38 Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapse

39 In vitro-induced resistance to the deoxycytidine analogues cytarabine (AraC) and 5-aza-2′-deoxycytidine (DAC) in a rat model for acute myeloid leukemia is mediated by mutations in the deoxycytidine kinase ( dck ) gene

40 Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis

41 Recurrent CCND3 mutations in MLL-rearranged acute myeloid leukemia

42 Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991

43 Unusual relapse of acute myeloid leukemia: granulocytic sarcoma presenting as an acute paraplegia

44 Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia: a single center experience

45 normal hematopoietic progenitor subsets have distinct reactive oxygen species, bcl2 and cell-cycle profiles that are decoupled from maturation in acute myeloid leukemia.

46 generation and characterization of a human induced pluripotent stem (ips) cell line derived from an acute myeloid leukemia patient evolving from primary myelofibrosis carrying the calr 52 bp deletion and the asxl1 p.r693x mutation

47 the partial duplication of the 5′ segment of kmt2a revealed kmt2a-mllt10 rearrangement in a boy with acute myeloid leukemia

48 response and survival in acute myeloid leukemia patients not candidates to transplantation treated with azacitidine versus palliative treatment: a retrospective study

49 the relationship between clinical feature, complex immunophenotype, chromosome karyotype, and outcome of patients with acute myeloid leukemia in china

50 a paraneoplastic syndrome characterized by extremity swelling with associated inflammatory infiltrate heralds aggressive transformation of myelodysplastic syndromes/myeloproliferative neoplasms to acute myeloid leukemia: a case series

51 acute panmyelosis with myelofibrosis - a rare subtype of acute myeloid leukemia

52 acute myeloid leukemia presenting with pulmonary tuberculosis

53 prognosis and therapy when acute promyelocytic leukemia and other “good risk” acute myeloid leukemias occur as a therapy-related myeloid neoplasm

54 p53/surviving ratio as a parameter for chemotherapy induction response in children with acute myeloid leukemia

55 erratum to “dnmt3a mutations in patients with acute myeloid leukemia in south brazil”

56 early development of acute myeloid leukemia following treatment of osteosarcoma: a case report and review of the literature

57 daunorubicin, cytarabine, and cladribine regimen plus radiotherapy and donor lymphocyte infusion for extramedullary relapse of acute myeloid leukemia after hematopoietic stem cell transplantation

58 acute myeloid leukemia following radioactive iodine therapy for papillary carcinoma of the thyroid

59 stem cell modeling of core binding factor acute myeloid leukemia

60 invasive tracheobronchial aspergillosis in a child with acute myeloid leukemia

61 rabdomiosarcoma embrionario simulando la fase inicial de una leucemia mieloide aguda al debut.: presentación de un caso embryonal rhabdomyosarcoma mimicking the initial phase of an acute myeloid leukemia at onset:: a case presentation

62 Tetraspanin CD82 drives acute myeloid leukemia chemoresistance by modulating protein kinase C alpha and β1 integrin activation.

63 CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation - Journal of Hematology & Oncology

64 Early Fluorescence in situ Hybridization Assessment during Acute Myeloid Leukemia Induction Chemotherapy

65 Haplotype mismatched transplantation using high doses of peripheral blood CD34+ cells together with stratified conditioning regimens for high-risk adult acute myeloid leukemia patients: a pilot study in a single Korean institution

66 Gene Expression Profiling To Predict Viridans Group Streptococcal and Invasive Fungal Infection in Pediatric Acute Myeloid Leukemia: A Brief Report from the Children’s Oncology Group

67 Up-Regulation of P21 Inhibits TRAIL-Mediated Extrinsic Apoptosis, Contributing Resistance to SAHA in Acute Myeloid Leukemia Cells

68 Comparison of Different Conditioning Regimens of Haploidentical Hematopoietic Stem Cell Transplant in Patients With Acute Myeloid Leukemia.

69 AZACYTIDINE (A) ASSOCIATED WITH VITAMINS (B1, C, AND D) IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA.

70 Use of cellular immunotherapy for treatment of refractory acute myeloid leukemia

Keyword Connections

Journals

Research Groups

Bibliographies